Roxane Laboratories: FTC's Generic Market Analysis Forcing Divestures Even In Diverse Categories
Hikma must divest rights to three drugs under Roxane Labs deal as Federal Trade Commission aims to preserve as many as five competitors in some markets.
Read full article »
President
Gerald C. Wojta
Roxane Laboratories engaged in the research and development of generic pharmaceuticals.
Read more